Breaking News
ADC Therapeutics SA (ADCT) Reports Wider Loss Q4 EPS Estimates by 85.1%
ADC Therapeutics SA (ADCT) posted a Q4 2025 adjusted loss of $0.29 per share, wider than the -$0.27 expected loss (8.1% wider). The company generated…